GNMX

Aevi Genomic Medicine, Inc.
GNMX

Overview Fund Activity
Delisted

GNMX was delisted on the 3rd of February, 2020.

Back to rankings

26 hedge funds and large institutions have $11.8M invested in Aevi Genomic Medicine, Inc. in 2013 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 7 reducing their positions, and 3 closing their positions.

Holders
26
Holders Change
+3
Holders Change %
+13.04%
% of All Funds
0.76%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
7
Reduced
7
Closed
3
Calls
$315K
Puts
–
Net Calls
+$315K
Net Calls Change
+$315K

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.67M
2
BIT
2
BlackRock Institutional Trust
California
$1.06M
3
Baillie Gifford & Co
3
Baillie Gifford & Co
United Kingdom
$623K
4
WA
4
WFG Advisors
Texas
$60K
5
VanEck Associates
5
VanEck Associates
New York
$53K

Top Sellers

1
PA
1
Perceptive Advisors
New York
$367K
2
BCM
2
Bridgeway Capital Management
Texas
$240K
3
Morgan Stanley
3
Morgan Stanley
New York
$14K
4
HighTower Advisors
4
HighTower Advisors
Illinois
$0
5
CA
5
Commerzbank Aktiengesellschaft
Germany
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
HighTower Advisors
26
HighTower Advisors
Illinois
– -$129K -16,600 Closed
CA
27
Commerzbank Aktiengesellschaft
Germany
– -$117K -15,000 Closed
1
2